Work

Genetically engineered herpes virus for the treatment of cardiovascular disease

Year: 2001

Type: article

Abstract: The present invention provides methods of expressing a nucleic acid or producing a proteinaceous composition encoded by a nucleic acid in vascular and cardiovascular cells by administration of a herpesvirus vector. The present invention provides methods of producing a therapeutic benefit in vascular and cardiovascular tissue by administration of a herpesvirus vector. In additional aspects, the invention concerns combination therapies for vascular and cardiovascular diseases comprising administration of a herpesvirus vector and treatment with at least one addition pharmacological agent or surgical procedure.

Source: University of Chicago

DOI: 10.6082/aweq1-vkd67

Authors: Schwartz, Lewis B., Weichselbaum, Ralph R., Roizman, Bernard

Institution: University of Chicago

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7163048029

FWCI:

Cites:

Cited by:

Related to: 10